MATTHEW KING: Open Payments
NPI 1285150276 · SHEFFIELD, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$519 in 34 payments from 9 companies in 2025. Trend: 2023 $285 · 2024 $674 · 2025 $519
Food & beverage: $519
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $224 |
| Corcept Therapeutics | 3 | $59 |
| Lundbeck LLC | 3 | $49 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| PFIZER INC. | 2 | $40 |
| Dexcom, Inc. | 2 | $35 |
| ABBVIE INC. | 2 | $33 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $14 |
Products named: Ozempic, Wegovy, Korlym, VYEPTI, Dexcom G6 Transmitter, BREZTRI, PREVNAR 20, VRAYLAR.
Industry payments across AL — which companies pay providers there.
